• / Free eNewsletters & Magazine
  • / My Account
Home>IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015

IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015

3party Content

Tue, 30 Jun 2015

BUENA, N.J., June 30, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted its fifth abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA) of 2015, which brings the
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.